Bell G D, Clegg R J, Ellis W R, Middleton B, White D A
Br J Pharmacol. 1984 Jan;81(1):183-7. doi: 10.1111/j.1476-5381.1984.tb10759.x.
The chemical trimethylcyclohexanol (TMC) is closely related to menthol, the major component of a terpene preparation with known choleretic and cholelitholytic activity. Its effects on hepatic cholesterol synthesis and bile secretion were examined in the rat. In both acute and long-term dosing experiments TMC significantly inhibited hepatic S-3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase. TMC was a potent choleretic, with detectable effects on bile flow at low doses, which also reduced coupling of cholesterol secretion to bile salt secretion. Single large doses tended to lower biliary cholesterol output and caused significant reduction in cholesterol saturation index after biliary diversion for 1 h. TMC and its widely prescribed ester cyclandelate, which is rapidly degraded to TMC after ingestion, should be investigated further as potential cholelitholytic treatments in man.
化学物质三甲基环己醇(TMC)与薄荷醇密切相关,薄荷醇是一种具有已知利胆和溶石活性的萜类制剂的主要成分。在大鼠中研究了其对肝脏胆固醇合成和胆汁分泌的影响。在急性和长期给药实验中,TMC均显著抑制肝脏3-羟基-3-甲基戊二酰辅酶A(HMGCoA)还原酶。TMC是一种强效利胆剂,低剂量时对胆汁流量有可检测到的影响,这也减少了胆固醇分泌与胆盐分泌的偶联。单次大剂量给药往往会降低胆汁胆固醇输出量,并在胆汁引流1小时后使胆固醇饱和指数显著降低。TMC及其广泛处方的酯环扁桃酯(摄入后会迅速降解为TMC)作为人类潜在的溶石治疗方法应进一步研究。